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Abstract 
A brief summary of common Clostridium sp. affecting cattle and sheep is provided. New 
insights and unusual presentations of disease entities caused by C. botulinum, C. chauvoei, C. 
sordellii, C. difficile and C. perfringens, such as fatal abomasitis in calves and lambs, are 
highlighted. 
 
Introduction 
A wide variety of clostridia pathogens may affect cattle and sheep. An overview of the common 
disease entities is given in Table 1 and further details may be found in contemporary textbooks 
on large animal veterinary medicine, such as Radostits and others (2006). This paper will 
highlight some more unusual presentations, potentially novel disease entities, and aspects of 
clinical management, including diagnosis. 
 
Clostridial diseases have several features in common: pathogenesis caused by toxins; a 
necrotising, and often haemorrhagic, pathology; rapid progression and death; and although 
potentially ubiquitous, typically confined to small regional areas or individual farms where soil 
or feed has become contaminated with pathogen spores. Risk factors include processes that 
reduce oxygen tension in, or trauma to, tissues (bruising, injections, dystocia, surgical tissue 
trauma, liver fluke). Most Clostridium species can be found in small numbers in the intestine of 
healthy ruminants (and other mammals), and some are post-mortem invaders. Definite diagnosis, 
therefore, relies on evidence of toxins or immune-system reaction (e.g. fluorescent antibody 
test). In cases of C. perfringens enterotoxaemia, studies have looked at the diagnostic value of 
localised overgrowth (colony forming units per millilitre of intestinal contents), with ambiguous 
results (Lebrun and others, 2010; Uzal, 2004; Valgaeren and others, 2013). 
 
Treatment of individual cases is often unrewarding. There is little antimicrobial resistance and 
so, in theory, any product with an anaerobe spectrum is suitable, (e.g. procaine penicillin at 
above label dose of 25,000 – 40,000 IU per kg BW, or ceftiofur). However, the rapid disease 
process limits the usefulness of antibiosis, because it will not reverse the effect of toxins once 
bound. The often per-acute nature also limits the use of serotherapy. However, both treatment 
modalities may be useful in cohort animals not yet showing overt clinical signs. Antimicrobials 
must be used with care in botulism cases, as several potentiate the neuro-muscular block (e.g. 
penicillin, oxytetracyline). Botulism cases may benefit from intravenous administration of 
transmitter release enhancers (e.g. guanidine hydrochloride), if licensed. Antitoxins are effective 
against bound toxins but, currently, only tetanus antitoxin is available. Force-feeding is often 
necessary in patients affected by clostridial diseases with neurotoxic effects (e.g. botulism, 
tetanus), and the creation of a rumen fistula aids this. Further nursing care should include a low-
stimulant environment. 
 
Vaccines for cattle and sheep are available in the UK, varying in the species of Clostridium 
included, as well as the C. perfringens toxoids.   
 
New aspects and unusual presentations to highlight with regard to selected species of 
Clostridium include: 
 
Clostridium botulinum 
 Substantially more incidents of botulism were observed in cattle and sheep by AHVLA 
between 2003 – 2009 than in the 1990’s (187 incidents from 2003 – 2009 compared to 22 
between 1990-2000; Payne and others, 2011). In addition, type D toxin was involved in a 
much higher proportion of cases than previously observed. 
 
 Typical outbreaks involve a relatively small number of animals (up to 10% of group). 
However, high losses can occur. In one such example, in spring 2014 AHVLA dealt with an 
outbreak of botulism in a Welsh dairy herd that resulted in the death of a large number of 
animals (around 175 cattle out of 1200 over one week). The cause was suspected to be 
ingestion of toxin from a decomposing animal carcass that was accidentally incorporated in 
the silage clamp. Possibly contributing factor was that the clamp was opened after only three 
weeks of ensiling.  
 
Periodic reviews on the public health risk posed by botulism toxin C and D have so far 
concluded that there is no need for compulsory restriction of meat or milk from affected 
cattle herds entering the food chain (ACMSF, 2006). A follow-on report in 2007 came to the 
same conclusion with regard to sheep and goat milk and meat. However, a voluntary 
restriction of clinically affected cattle is usually followed, remaining in place for 18 days 
after recovery. 
 
 Field reports from Denmark describe a clinical picture that may reflect early or mild 
infection with C. botulinum (J. Erri, 2014, personal communication). Cows demonstrate 
altered drinking behaviour, raising their heads after every sip, possibly suggesting a 
swallowing inability. In the herds observed, water intake is markedly reduced (60-70 litres 
per head, daily milk yield of about 30 litres), with clinical signs of dehydration. Other 
clinical signs in these herds include flaccid tails (resulting in injury in herds using automatic 
scrapers), recumbency in cows two to three months in milk, and sudden death. After 
vaccinating against C. botulinum, water consumption was observed to rise by 30-40%.  
 
 Visceral botulism has been postulated as a new clinical presentation in cattle by German 
colleagues (Böhnel and others, 2001). Especially cattle in the peri-partum period are affected, 
with the most prominent sign being disturbances of the digestive tract (indigestion, with 
constipation alternating with diarrhoea). Other signs include paralysis, acute laminitis, udder, 
limb and ventral oedema, increased respiratory effort, and venous engorgement and 
pulsation. Effects of the botulinum toxin on the autonomous nervous system are recognised 
in humans, and C. botulinum type C is suspected in equine grass sickness. 
 
 Diagnostic advancements: Field diagnosis relies on the presence of clinical signs, with 
several animals affected and exclusion of differential diagnoses. Mouse inoculation is the 
traditional laboratory test to confirm. Because not all cases are positive on the mouse test, 
and with a drive to reduce the number of laboratory animals in testing, alternative 
confirmatory tests have been explored. Performing a single antibody ELISA was found 
unhelpful in the diagnosis of type D botulism in both clinically affected and in-contact cattle 
(Mawhinney and others, 2012).  
 
 
 
Clostridium chauvoei 
 The most common, and best known, manifestation of this pathogen is a necrotising myositis 
with haemorrhages into muscle and connective tissue. The colloquial name ‘blackleg’ is 
somewhat misleading, as any skeletal muscle group may be involved. C. chauvoei may 
occasionally cause meningeal lesions, as well as present as cardiac form with heart muscle 
myositis and fibrinous pericarditis. A large proportion of reports of the cardiac form involve 
suckling calves. A more unusual presentation involves necrotising lesions of the tongue and 
intestine (Harwood and others, 2007)  
 
 A report of a large-scale outbreak in Norwegian beef animals highlights that the disease is 
not confined to animals at pasture (Groseth and others, 2011). Substantial soil contamination 
of silage was the suggested source of the clostridia spores in this outbreak. 
 
 Vaccination is a commonly-used tool to control blackleg. A recent evidence-based review of 
vaccination against C. chauvoei found only few studies investigating the efficacy of 
vaccination to prevent disease and mortality (Uzal, 2012). However, protection appeared to 
be close to 100% in the three studies using experimental challenge. Only one paper studied 
the length of protection, finding that full protection lasted six months, reducing to 50% by 
twelve months after vaccination. The review found no publications comparing efficacy based 
on age at vaccination, number of doses, or monovalent versus polyvalent vaccines.  
 
C. sordellii  
 
Compared to some other clostridia species, C. sordellii relatively rarely causes substantial 
disease problems, but it must be remembered that only the 10-in-1 vaccines cover this pathogen. 
 A fatal abomasitis is recognised in young lambs and calves caused by this pathogen (SAC 
2012). Typically, just two to three animals out of a larger group are affected. Unsanitary milk 
feeding and high exposure to faecel material are risk factors. Sarcina sp. can cause a similar 
abomasitis with similar risk factors (Edwards and others, 2008), as can C. perfringens in 
calves (Van Kruiningen and others, 2009). 
 C. sordellii may also be involved in cases of malignant oedema, on its own or in combination 
with other clostridial pathogens (including C. septicum, C. chauvoei, C. novyi, C. perfringens 
type A). When associated with unhygienic injection techniques (or contamination of the 
product used), fatalities in a substantial number of treated animals may result, such as in the 
case report by Costa and others (2007), where several dozen sheep out of a flock of 1000 
developed malignant oedema around the injection site of a clostridial vaccine. The same 
needle had been used for the entire flock. 
 
C. difficile 
 C. difficile causes a serious infection in humans and the number of cases is increasing. 
Traditional risk factors have been antibiotic treatment and a stay in hospital, but infections 
originating in the community are now recognised more frequently. This has prompted a 
closer look at farm animals as potential source of the infection in humans.  
Studies from Switzerland (cattle and goats; Romano and others, 2012) and Australia (sheep; 
Knight and Riley, 2013) come to the similar conclusion that the overall carriage of this 
pathogen is low in live animals, with prevalence of positive faecal samples in adults of 0.5 % 
(sheep) and 1.5 % (cattle), with higher levels in youngstock of 6.5% (lambs) to 12.7 % 
(calves). Samples taken in the farm environment had a prevalence of 21 %. While the 
pathogen was found, the researchers conclude that these levels are unlikely to be a major risk 
for human infections. 
 
C. perfringens 
 This pathogen continues to receive attention because of the potent toxins it is capable of 
producing and its role in food poisoning. It remains a serious pathogen in ruminants. 
Advances in understanding toxin actions, diagnosis, clinical veterinary presentation and 
prophylaxis are summarised in recent reviews (Lebrun and others, 2010; Uzal, 2004 and 
2014).  
 C. perfringens Type A is implicated in necrotic enteritis of calves and haemorrhagic bowel 
syndrome in dairy cattle (also referred to as Jejunal haemorrhagic syndrome; Elhanafy, 
2013). Just as with other Clostridium sp., this pathogen is commonly present in small 
numbers in the intestine of healthy animals. The history of patients often reveals potentially 
predisposing factors that may favour overgrowth of the pathogen, such as concurrent other 
GI-tract infections (e.g. E. coli in calves), carbohydrate-rich / fibre-poor diets, or recent stress 
events. Affected dairy cows initially show rather non-specific clinical signs, such as reduced 
food intake, depression, and reduced rumen motility and faecal production, common to a 
range of differential diagnosis affecting early-lactation animals.  
 In small ruminants, C. perfringens Type B, C and D are regarded as main pathogens. 
However, Type A is being recognised as a potential cause of mortality in lambs and kids and 
some case reports suggest that the toxin beta-2 may be responsible, protection against which 
is currently not afforded by the commercially available vaccines (Greco and others, 2005). 
Type A should be considered especially in cases of apparent vaccine failure. 
 Type E is regarded as an infrequent cause of fatal enterotoxaemia in calves (Songer and 
Miskimmins, 2004) and lambs, and has now also been described in adult beef cows in 
Argentina (Redondo and others, 2013). Current vaccines do not afford meaningful protection 
against Type E. 
 C.perfringens may cause gangrenous mastitis in ewes, although is far less common than 
Staphylococcus aureus in such cases (Mork and others, 2007). 
Table 1: Overview of clostridial infections recognised in cattle and sheep. 
 
Pathogen Disease name Aetiology Main clinical features Control 
C. botulinum Botulism 1) Ingestion of pre-formed toxin, e.g. 
ensiled animal carcasses, particularly 
where chicken litter applied to fields. 
Also carcass decomposing in water 
troughs 
2) Gastro-intestinal infection with 
pathogen. Decaying plant material (e.g. 
big-bale silage), brewer’s / high 
moisture grains are a risk. 
3) Type C and D toxin most commonly 
involved in cattle and sheep disease.  
Neurotoxin causes flaccid paralysis, progressive; 
leading to recumbency and death after several 
days. 
In sheep, staggering gait, stiffness and head 
bobbing may be seen prior to flaccid paralysis. 
 
Avoid chicken litter on pasture land, or 
other direct or close proximity contact. 
Check fields for animal carcasses prior 
to cutting. Ensile for at least one month 
to ensure sufficient fermentation. 
Vaccination only under VMD Special 
Treatment Licence. Antitoxin not 
available in the UK. Antibiotics of 
limited use once the toxin is bound, 
and may enhance the neuro-muscular 
block (see main text: introduction) 
C. chauvoei Blackleg 1) Trauma to affected area. 
2) Iatrogenic: injection site related 
3) Ingestion of spores 
Myositis affecting skeletal muscles, with soft 
tissue swelling and severe lameness. Later on 
cold extremities with reduced sensation. Cases 
also show lethargy, anorexia and sometimes 
pyrexia. Rapid deterioration and death. May also 
affect heart, meninges, tongue and intestine, with 
acute haemorrhage and necrosis. 
High-dose penicillin in acute cases or 
prophylactic to cohorts. 
Vaccination available. Spores may be 
brought onto farm with top soil or 
conserved forages. 
C. haemolyticum Bacillary 
haemoglobinuria 
Ingestion of infected material. Summer 
and autumn months, on irrigated 
(natural or artificial) or previously 
flooded pastures. May be present on 
hay. 
Pyrexia, abdominal pain, inappetence, rumen 
stasis, toxaemia, haemoglobinuria. Abortion in 
surviving females is common. 
Treatment with antimicrobials, fluid 
therapy, blood transfusion.  
Vaccination, timed for risk period. 
C. novyi 
Type B 
Black disease Associated with cereal-rich diets and 
liver fluke. Localised areas, more 
common in sheep than cattle, and 
typically adults in good condition. 
Seasonal in line migration of immature fluke. 
Infectious necrotising hepatitis. Pyrexia; blood 
clots rapidly; dull, depressed, reluctant to move. 
Reduced bowel sounds, abdominal pain over liver 
High-dose antibiotics. Vaccination and 
liver fluke control. 
C. perfringens     
Type A 1) HBS
1
  
2) Enterotoxaemia 
in cattle 
3) Malignant 
oedema 
 
1) & 2): intensively managed cattle; 
Enterotoxaemia typically affects young 
and well-performing animals; fibre-
poor diets and stress are risk factors 
3)  usually in combination with other 
Clostridium spp. 
Sudden death, signs of toxaemia with multiple 
organ failure, haemorrhagic enteritis (small 
intestine) 
Vaccine: must contain alpha-, beta- 
and epsilon toxoid. Antibiosis or 
serotherapy: often disease too acute 
Probiotics: empirical suggestion at 
times of stress or diet change 
     
                                                 
1 Haemorrhagic bowel syndrome, also referred to as Jejunal haemorrhagic syndrome 
Type B Lamb dysentery, 
Calf 
enterotoxaemia 
Lambs are affected at few days old. 
Proliferation of pathogen in gut, toxin 
release leads to enterotoxaemia.  
Haemorrhagic enteritis with diarrhoea Abdominal 
pain, tenesmus, lack of suckling. Occasionally 
causes brain oedema, with neurological signs. 
 
     
Type C Struck (sheep), 
Calf 
enterotoxaemia 
Proliferation of pathogen in gut, toxin 
release leads to enterotoxaemia 
Necrotising enteritis with abdominal pain, bloody 
diarrhoea; particularly young animals 
 
     
Type D Pulpy kidney 
disease 
Vascular permeability increases, 
leading to oedema and excess free 
fluid; sheep more susceptible than 
cattle. Up to and shortly after weaning. 
Typically in good condition, on good 
nutritional plane. 
Oedema of brain, lung, hydropericardium; 
dyspnoea, neurological signs with opisthotonus, 
paddling, blindness, convulsions. 
Hyperglycaemia and glycosuria. 
Vaccination, feed restriction. Disease 
progression typically too fast for 
treatment. 
     
Type E Enterotoxaemia Lambs and calves   
C. piliforme Tyzzer’s Disease Entero-hepatic infection. Only 
occasionally reported in cattle (young 
calves) and sheep. 
Necrotising hepatitis. Lethargy, diarrhoea, 
illthrift, pyrexia, jaundice, shock. 
Antibiosis and supportive therapy. 
C. septicum 1) Malignant 
oedema 
2) Braxy 
1) Often in association with other 
Clostridium species (e.g. C novyi, C. 
sordellii, C. chauvoei). Pathogen or 
spores typically enter at site of tissue 
injury, including injection / blood 
sampling sites 
2) Cold weather (frost and snow). 
Typically young / yearling sheep. 
1) Initially hot, painful swelling  and oedema at 
site of injury. Later cold and desensitised. 
Crepitus due to subcutaneous emphysema. 
2) Abomasitis 
1) High-dose antibiotics. Debate 
whether opening affected area to 
increase oxygen exposure is helpful. 
Observing injection hygiene, including 
drug bottles. 
2) None valuable. 
C. sordellii  Environmental pathogen, commonly 
found in cereal or soil. Hardy, e.g. 
tolerates very low pH (>1) 
1) Fatal abomasitis in young lambs, with 
haemorrhage oedema, congestion, emphysema.  
2) Malignant oedema, often in combination with 
other clostridial pathogens (e.g. C. septicum) 
Abomasitis: Risk factors appear to 
include supplementary milk feeding 
and unhygienic conditions with 
exposure to faecal material 
C. tetani Tetanus 1) Entry through wounds (incl. 
surgical) or mucous membranes (e.g. at 
parturition).  
2) Contaminated injectable solutions 
Neurotoxin advances via nerve trunks 
to CNS. 
Muscle stiffness and rigidity, with failure of 
respiratory muscles eventually causing death. 
Signs advance from point of entry. Rumen 
tympany, raised tailhead, immobile ears, lock 
jaw, hyperaesthesia (light, noise) and lateral 
recumbency with opisthotonus and extended 
limbs are commonly observed. 
Tetanus antitoxin, high-dose penicillin 
or ceftiofur, muscle relaxant (e.g. 
opoids; if licensed), force feeding, dark 
and quiet environment. Vaccination 
prior to routine procedures (castration, 
docking, ear tagging), antibiosis at 
time of procedure. Good hygiene 
during routine procedures and in 
parturition environment. 
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